ANRO vs LXRX
Comparison between Alto Neuroscience Inc (ANRO, Company) and Lexicon Pharmaceuticals Inc (LXRX, Company).
Both ANRO and LXRX are from the Healthcare sector.
ANRO vs LXRX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
ANRO
$954M
Winner
LXRX
$958M
Max Drawdown
Winner
ANRO
91.74%
LXRX
99.91%
Sharpe Ratio
Winner
ANRO
2.27
LXRX
1.17
5Y Beta
ANRO
1.26
Winner
LXRX
1.09
Industry
ANRO
Biotechnology
LXRX
Biotechnology
P/E Ratio
ANRO
-11.20
Winner
LXRX
-31.76
PEG Ratio
Winner
ANRO
-2.89
LXRX
-0.14
Debt to Equity
Winner
ANRO
6.58%
LXRX
24.49%
Free Cash Flow Yield
ANRO
-6.59%
Winner
LXRX
-4.05%
P/S Ratio
ANRO
N/A
LXRX
15.18
P/B Ratio
Winner
ANRO
4.32
LXRX
5.10
ANRO vs LXRX - Historical Returns
Returns include dividend reinvestment.
1M
Winner
ANRO
+7.47%
LXRX
+3.15%
3M
ANRO
+9.18%
Winner
LXRX
+36.31%
6M
Winner
ANRO
+61.17%
LXRX
+34.71%
1Y
Winner
ANRO
+769.16%
LXRX
+102.65%
5Y(CAGR)
ANRO
N/A
LXRX
-7.60%
10Y(CAGR)
ANRO
N/A
LXRX
-17.59%
Max(CAGR)
Winner
ANRO
+10.96%
LXRX
-14.27%
ANRO vs LXRX - Annual Returns (2000 - 2026)
Returns include dividend reinvestment.
| Year | ANRO | LXRX |
|---|---|---|
| 2026 | +61.36% | +100.88% |
| 2025 | +306.39% | +47.99% |
| 2024 | -79.57% | -53.55% |
| 2023 | N/A | -23.12% |
| 2022 | N/A | -50.90% |
| 2021 | N/A | +11.93% |
| 2020 | N/A | -16.38% |
| 2019 | N/A | -39.94% |
| 2018 | N/A | -34.39% |
| 2017 | N/A | -30.42% |
| 2016 | N/A | +5.17% |
| 2015 | N/A | +105.98% |
| 2014 | N/A | -49.17% |
| 2013 | N/A | -24.41% |
| 2012 | N/A | +76.80% |
| 2011 | N/A | -14.00% |
| 2010 | N/A | -16.76% |
| 2009 | N/A | +18.06% |
| 2008 | N/A | -54.10% |
| 2007 | N/A | -17.89% |
| 2006 | N/A | -5.25% |
| 2005 | N/A | -50.68% |
| 2004 | N/A | +28.18% |
| 2003 | N/A | +14.37% |
| 2002 | N/A | -57.69% |
| 2001 | N/A | -17.57% |
| 2000 | N/A | -11.31% |
ANRO vs LXRX Drawdown Comparison
The maximum drawdown for ANRO was -91.74%, occurring on Apr 4, 2025. Recovery took 523 trading sessions.
The maximum drawdown for LXRX was -99.91%, occurring on Mar 3, 2025. This drawdown has not yet recovered.
The current ANRO drawdown is -4.63%. The current LXRX drawdown is -99.31%.
| Rank | ANRO | LXRX |
|---|---|---|
| #1 | -91.74% Feb 5, 2024 - Mar 9, 2026 | -99.91% Jul 21, 2000 - Mar 3, 2025 |
| #2 | -34.20% Apr 17, 2026 - Jun 29, 2026 | -51.33% Apr 7, 2000 - Jun 20, 2000 |
| #3 | -17.74% Mar 16, 2026 - Apr 13, 2026 | -15.33% Jul 10, 2000 - Jul 20, 2000 |
| #4 | -11.72% Jun 29, 2026 - Jul 2, 2026 | -8.08% Jun 21, 2000 - Jun 23, 2000 |
| #5 | -5.05% Mar 9, 2026 - Mar 11, 2026 | -5.17% Jun 28, 2000 - Jul 5, 2000 |
| #6 | -3.56% Mar 11, 2026 - Mar 16, 2026 | N/A |
| #7 | -1.36% Apr 14, 2026 - Apr 16, 2026 | N/A |
Correlation
Correlation between ANRO and LXRX is 0.68 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.68
-101
Select Stocks to Compare
Popular: ANRO vs SPYLXRX vs SPY
More Comparisons
Compare with similar stocks